Edwards Lifesciences Poland Sp. z o.o. represents the Polish presence of Edwards Lifesciences, focused on advanced technologies for structural heart and cardiac surgery care pathways. The product and therapy portfolio includes transcatheter heart valve technologies, transcatheter mitral and tricuspid technologies, and surgical valve technologies supporting heart valve repair and replacement procedures, with flagship platform branding that includes SAPIEN within the transcatheter aortic valve therapy ecosystem. The company also supports hemodynamic monitoring solutions used in individualized patient management, aligned with the Edwards critical care product heritage and manufacturing base. Geographic scope is Poland, serving hospitals and specialized cardiac centers while leveraging the global Edwards organization operating across international healthcare markets. Key assets include access to the Edwards innovation pipeline and clinical technology platforms in heart valve and structural heart therapy, specialized clinical support resources, and the Edwards brand recognized in cardiovascular device segments. Strategic focus is on clinically differentiated technologies that improve outcomes in cardiovascular disease treatment, sustained innovation in transcatheter and surgical valve solutions, and long-term partnership with healthcare providers through therapy adoption support and product lifecycle servicing.
Headquarters
Ul. Aleje Jerozolimskie 100
Warsaw; Mazowieckie;
Postal Code: 00-807
Contact Details: Purchase the Edwards Lifesciences Poland Sp. z o.o. report to view the information.
Website: https://www.edwards.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service